Skin and Subcutaneous Tissue Thickness at Insulin Injection Sites in Chinese Diabetes Patients: Clinical Implications

W. Wang,Xiaohui Guo,Gang Shen,Guang‐Yi Bai,Wei Zheng,J. Liu,Laurence Hirsch,Kenneth Strauss

DOI: https://doi.org/10.1016/j.diabet.2016.04.010

IF: 8.254

2016-01-01

Diabetes & Metabolism

Abstract:Diabetes & Metabolism - In Press.Proof corrected by the author Available online since jeudi 9 juin 2016

What problem does this paper attempt to address?

Prevalence of Lipohypertrophy in Insulin-Treated Diabetes Patients: A Systematic Review and Meta-Analysis

Nan Deng,Xiaoyi Zhang,Fangfang Zhao,Ya Wang,Hong He

DOI: https://doi.org/10.1111/jdi.12742

2018-01-01

Journal of Diabetes Investigation

Abstract:Aims/IntroductionInsulin-treated diabetes patients are at high risk for lipohypertrophy (LH), but this clinical problem has been overlooked by some medical professionals. In addition, studies differed from each other significantly in regard to the prevalence of LH. The present systematic review aimed to determine pooled prevalence levels of LH among insulin-injecting diabetes patients. Materials and MethodsFour electronic databases (PubMed, EMBASE, The Cochrane Library and Scopus) were searched for eligible studies from their inception until April 2017, and reference lists were searched manually to identify additional studies. Studies containing data on LH in patients with diabetes mellitus were included. Meta-analysis was carried out with a random effects model. ResultsA total of 26 studies with a total of 12,493 participants met the inclusion criteria. Meta-analysis showed that the pooled prevalence of LH was 38% (95% confidence interval [CI] 29-46%, I-2 = 99.1%). The main influence on LH was the type of diabetes mellitus. The pooled prevalence of LH among patients with type 2 diabetes mellitus was higher than patients with type 1 diabetes mellitus (49%, 95% CI 23-74% vs 34%, 95% CI 19-49%). The pooled prevalence of LH of studies involving a mixed type of diabetes mellitus was 37% (95% CI 25-48%, I-2 = 98.3%). ConclusionThe prevalence of LH was high in insulin-treated diabetes patients. It showed that diabetes nurses should screen for LH regularly in their patients, and teach them how to prevent LH in their daily management of diabetes mellitus.
Artificial Intelligence-Assisted Bioinformatics, Microneedle, and Diabetic Wound Healing: A "new Deal" of an Old Drug.

Yanan Xue,Cheng Chen,Rong Tan,Jingyu Zhang,Qin Fang,Rui Jin,Xiangyu Mi,Danying Sun,Yinan Xue,Yue Wang,Rong Xiong,Haojian Lu,Weiqiang Tan

DOI: https://doi.org/10.1021/acsami.2c08994

IF: 9.5

2022-01-01

ACS Applied Materials & Interfaces

Abstract:Diabetic wounds severely influence life, facing grand challenges in clinical treatments. The demand for better treatment is growing dramatically. Diabetic wound healing is challenging because of inflammation, angiogenesis disruptions, and tissue remodeling. Based on sequencing results of diabetic patients' skins and artificial intelligence (AI)-assisted bioinformatics, we excavate a potential therapeutic agent Trichostatin A (TSA) and a potential target histone deacetylase 4 (HDAC4) for diabetic wound healing. The molecular docking simulation reveals the favorable interaction between TSA and HDAC4. Taking advantage of the microneedle (MN) minimally invasive way to pierce the skin barrier for drug administration, we develop a swelling modified MN-mediated patch loaded with TSA to reduce the probability of injection-caused iatrogenic secondary damage. The MN-mediated TSA patch has been demonstrated to reduce inflammation, promote tissue regeneration, and inhibit HDAC4, which provides superior results in diabetic wound healing. We envisage that our explored specific drug TSA and the related MN-mediated drug delivery system can provide an innovative approach for diabetic wound treatment with simple, effective, and safe features and find a broad spectrum of applications in related biomedical fields.
Establishment of Hyperinsulinemic Euglycemic Clamp Technique and the Reference Value of Insulin Sensitivity Index in Chinese

ZHAO Wei-gang,YUAN Tao,SUN Qi,FU Yong,YANG Guo-hua,DONG Ying-yue,DONG Ya-xiu,WANG Heng

DOI: https://doi.org/10.3760/cma.j.issn.1674-635x.2009.01.006

2009-01-01

Abstract:Objective To establish the technique of hyperinsulinemic euglycemic clamp and to study the reference value of insulin sensitivity index in healthy Chinese. Methods According to the feedback mathematical model developed by DeFronzo, the technique of hyperinsulinemic euglycemic clamp was used in 90 healthy Chi- nese [ male:female =71 = 19; age; (28. 3±6. 1) years; body mass index (20. 9±1.5) kg/m2 ] to study die glu-cose metabolized rate. Blood samples were obtained at timed intervals in the fasting state and during the clamp for the measurement of glucose, insulin and C peptide. Results During the clamp tests, the blood glucose levels were con-trolled within 10% of target value. The coefficient of variation of glucose levels was 3. 8% 0.1%. In the steady state, the insulin sensitivity index (glucose metabolized rate, M value ) was (7.78±2.30) mg· kg-1 min-1, which was distributed normally. The lowest quartile of M value was 6. 286 mg·kg -1 min-1'. The coefficient of variation of M value was 9.4%±2.8%. Conclusion The technique of hyperinsulinemic euglycemic clamp and the reference value of insulin sensitivity index in healthy Chinese are successfully established in our center.
Can the Upper Inner Side of the Thigh Become a New Option for Insulin Injection?

Jingyun Yuan,Yan Chen,Yanting Xuan,Lihong Cao,Jing Zhu,Fenrong Wang,Xiaona Zhou,Qing Ye,Liping Liao,Yun Zheng,Qun Zhou,Xiaohui Chen,Min Chen,Weibin Zhou

DOI: https://doi.org/10.1185/03007995.2016.1174107

2016-01-01

Current Medical Research and Opinion

Abstract:Objective: Sites for subcutaneous insulin injections include the upper arms, abdomen, buttocks and outer sides of the thigh. No similar study has explored the feasibility of using the inner side of the thigh for insulin injection, since the 4mm pen needles were introduced for clinical use. This study aimed to determine whether the inner side of the thigh is suitable for insulin injection.Research design and methods: Seventy-five patients with diabetes under insulin therapy from the Inpatient Department of Endocrinology were recruited for this non-blinded, non-randomized observational study. Subcutaneous adipose layer thicknesses of the upper, middle and lower area of the inner and outer thighs of 35 patients were measured by ultrasound, distance from the skin surface to the femoral deep vessels in 20 patients was measured, and insulin was injected at the upper inner and outer sides of the thigh in 20 patients. Pain perception, bleeding or bruising, leakage at the injection sites, blood glucose changes after insulin injection, and preferred ratings of the patients were measured.Clinical trial registration: ClinicalTrials.gov NCT02307968.Results: Subcutaneous adipose layer thicknesses at both the upper inner and outer thighs were more than 4mm and the minimum distance was 10 mm. Among the 100 injections at the upper inner thigh, only three incidents of perceived pain occurred. No bleeding or bruising and leakage were observed from the inner or outer sides. Furthermore, the difference in blood glucose control between insulin injections at the inner side and outer sides was not statistically significant. Patient ratings for injections at the inner side were similar to injections at the outer side. The key limitation of this study was the small sample size of adult patients as well as the non-randomized controlled design of this study.Conclusion: The upper inner thigh might be a new option for insulin injection rotation.
Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients with and Without Diabetes.

Hang Hu,Hongfei Jiang,Liyan Zhu,Xiaodan Wu,Chunmao Han

DOI: https://doi.org/10.1016/j.jcjd.2018.01.003

IF: 2.774

2018-01-01

Canadian Journal of Diabetes

Abstract:Objectives: Advanced glycation endproducts (AGEs) play a key role in the development of foot complications in people with diabetes. Skin autofluorescence (AF) might noninvasively determine tissue accumulation of AGEs. This study evaluated the association between skin AF and AGE contents in the deep tissues of those with diabetes and the further consequences of such contents. Methods: Between September 2014 and September 2015, we studied 33 patients, with and without diabetes, who had received lower-limb amputations. Skin AF was measured. Artery, nerve and skin were harvested during surgery. AGE contents were quantified using high-performance liquid chromatography mass spectrometry and were located by immunohistochemistry staining. Inflammatory cells were also located by immunohistochemistry, immunofluorescence and scanning electron microscopy. Results: Values of skin AF and AGE contents in artery, nerve and skin in patients with diabetes were higher than those in healthy patients. Skin AF was strongly affected by AGE contents in these tissues. AGE contents in various tissues were strongly correlated with each other. Differing AGEs were deposited in similar manners in the same tissues and were accompanied by inflammatory cells. Conclusions: AGE contents were strongly correlated with each other and were accompanied by inflammatory cells. Skin AF measurement could provide information about the systemic accumulation of AGEs. (C) 2018 Canadian Diabetes Association.
Correction to: Insulin Injection Technique in China Compared with the Rest of the World

Zhenqiang Song,Xiaohui Guo,Linong Ji,Xiao Huang,Laurence J Hirsch,Kenneth W Strauss

DOI: https://doi.org/10.1007/s13300-018-0538-6

Abstract:The original article can be found online.
Subclinical lipohypertrophy——Easily ignored complications of insulin therapy

Dan Luo,Yun Shi,Min Zhu,Hong Wang,Dan Yan,Jian Yu,JiaJia Ji,Xiaoyun Liu,Boqiang Fan,Yang Xu,Mei Zhang,Wei He,Jingjing Xu,Tao Yang

DOI: https://doi.org/10.1016/j.jdiacomp.2020.107806

IF: 3.219

2021-03-01

Journal of Diabetes and its Complications

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>Subclinical lipohypertrophy is a lesion meeting ultrasonic criteria for lipohypertrophy that was not detected by inspection and palpation. Little information is published on subclinical lipohypertrophy among insulin injection people with diabetes. We aimed to investigate the subclinical lipohypertrophy prevalence, risk factors, and the association between subclinical lipohypertrophy and glycemic control.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This observational study included 316 people with diabetes who had continuously received insulin therapy for at least one year. We performed ultrasound scanning and clinical examination for evidence of subclinical lipohypertrophy. Demographic characteristics, clinical information, and glycated hemoglobin were measured.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The overall prevalence of subclinical lipohypertrophy was 19.9%. By stepwise logistic regression, higher BMI (OR=1.44, 95%CI: 1.15-1.81, <em>P</em>=0.002), incorrect rotation of sites (OR=3.11, 95%CI: 1.02-9.47, <em>P</em>= 0.046) , insulin needle reusage for more than four times (OR=10.00, 95%CI: 3.23-31.02, <em>P</em>=0.000) and type 1 diabetes (OR=6.33, 95%CI: 1.32-30.47, <em>P</em>=0.021) remained associated with subclinical lipohypertrophy. Subclinical lipohypertrophy demonstrated a significant independent correlation with the nonoptimal glycemic control (OR=9.97, 95% CI: 3.46-28.75, <em>P</em>=0.000) when accounting for demographic and diabetes-related parameters.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Subclinical lipohypertrophy is common among insulin-injecting patients with diabetes and is related to glycemic control deterioration. Ultrasonography may be an ideal adjunct in the evaluation of easily ignored lipohypertrophy lesions, especially where poor glycemic control, incorrect injection behaviors, overweight or obesity are documented.</p>

endocrinology & metabolism
Insulin Injection Technique and Related Complications in Patients With Diabetes in a Northwest City of China

Tao Zhou,Yan Zheng,Juan Li,Xiangjun Zou

DOI: https://doi.org/10.1111/jep.14226

2024-11-06

Journal of Evaluation in Clinical Practice

Abstract:Objectives Appropriate insulin injection technique can help to enhance positive clinical outcomes in insulin‐treated patients. This cross‐sectional survey was undertaken to assess the present state of injection technique practices of patients administering insulin and the incidence of local complications associated with insulin injection. Methods This cross‐sectional study was conducted at 11 tertiary hospitals in Xi'an City. A total of 1370 patients with diabetes were enroled in the survey. Each patient was asked questions on the Injection Technique questionnaire, demonstrated insulin injection on an injection training pad and had their injection sites inspected by a nurse. Results About 98% of participants were type 2 diabetic patients. The 5 mm length needles were used by 640 (46.71%) patients. Around 1286 participants reused pen needles. Only one‐third of patients rotate the injection sites. Around 901 patients had ecchymosis at injection sites, 43 participants suffered rash and or pruritus and 661 patients had lipohypertrophy. About 2.99% of patients reported having infection at the injection sites. Most patients (72.55%) occasionally felt pain when injecting insulin. The results of the multivariable logistict analysis showed that gender (male), needle length, priming the pen before injections and correct site rotation were negatively associated with the incidence of injection site ecchymosis. Lower incidence of lipohypertrophy was associated with needle length 4 mm, needle length 6 mm, single use of pen needles, priming the pen before injections and correct site rotation. Higher incidence of injection site infection was related to not disinfecting injection sites before each injection. Conclusions Despite some improvements detected in some aspects of patients' insulin injection practice in recent years, a large gap still exists between insulin injection guidelines and patients' actual injection behaviour. Injection‐related complications at injection sites are still considerably common among our study population. Patients' education regarding insulin injection technique should be conducted repeatedly and regularly to make sure patients' compliance to injection guidelines.

medicine, general & internal,health care sciences & services,medical informatics
Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: A prospective cohort study in China

Wei Wang,Rong Huang,Yang Chen,Mei Tu

DOI: https://doi.org/10.1097/MD.0000000000026743

2021-07-23

Abstract:The aim of this study was to explore the values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy and further analyzing the impact of body mass index and subcutaneous fat thickness on ultrasound manifestations of lipohypertrophy.In this 3-month, prospective cohort study, a total of 162 patients with diabetes who used insulin therapy more than 1 year with unknown lipohypertrophy status were enrolled into this study. Demographic information, assessment of glycemic control and insulin injection technique were evaluated. Physical and ultrasound examination were separately performed to detect lipohypertrophy by a team of diabetes educator nurses or ultrasonographer in a blinded fashion. Patients with lipohypertrophy received insulin injection technique education based on ultrasound examination and Chinese guideline.Ultrasound examination detected 41.1% more patients (74.1% vs 52.5%; P < .001) with lipohypertrophy and 61.2% more lesions (216 vs 134; P < .001) than physical examination. Glycosylated hemoglobin A1c and fasting blood glucose were significantly decreased in patients with lipohypertrophy or subclinical lipohypertrophy (lipohypertrophy without visual and palpation changes) after receiving insulin injection technique education based on ultrasound examination and Chinese guideline than baseline at 3 months (P < .001). The proportion of lesions with ultrasound manifestation 2 (distortion of surrounding connective tissue) in obese and STF (>15 mm) groups were no more than 50% and showed a decreased trend with increased subcutaneous fat thickness and body mass index (P < .001).Lipohypertrophy has characteristic ultrasound manifestations which can detect more accurate results than palpation alone and provide detailed information to promote effective education on lipohypertrophy management, thereby improving glycemic control.
Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study

S K Y I Kodikara,J Kalubowila,N Atapattu,D S Warapitiya,M D M S Wijayabandara,L M D T Jayasekara,A Arunthavanathan,B C T A N W M R C S Kempitiya,K S H de Silva,K de Abrew

DOI: https://doi.org/10.1016/j.arcped.2020.05.008

Abstract:Background: Insulin therapy is essential for type 1 diabetes. While a reasonable glycemic control prevents complications, inadvertent intramuscular (IM) insulin injection results in hypoglycemia and fluctuations of blood glucose levels. Objective: To assess the subcutaneous thickness (SCt) at the potential insulin injection sites, in order to determine the suitable needle length. Methods: Diabetic and non-diabetic children (n=125; aged 2-14 years) attending a tertiary care hospital were examined, after excluding those who had skin abnormality at the injection site, were hospitalized for>3 days, or had any other chronic illnesses. Dermal thickness (Dt) and SCt at the potential insulin injection sites were measured with ultrasonography. Results: The mean age of the patients was 8 years and 57% were boys; mean Dt was 2.1±0.4 mm, SCt was 7.45.6±3.7 mm, and maximum SCt was 29.8 mm in the anterior abdominal wall. SCt increased with age and by raising a skin fold (sf). There was no difference (P>0.05) in Dt between genders, and limbs showed thinner Dt values than the abdomen. SCt changed with the injection site: it was the lowest in the thigh and the highest in the abdomen. SCt was thicker in females, with or without sf (P<0.001). For all sites, IM risk was high for 15-mm needles: it was highest in the thighs (98%) and reduced to 86% with sf. IM risk was low for 5-mm needles: it was highest in the thigh (38%), and reduced to 12% with sf. Compared with girls (up to 42%), IM risk was higher for boys (up to 54%), even for 5-mm needles with a sf. Conclusion: Using a short needle is recommended for children, particularly for boys. Regardless of the needle length, the raised sf technique is associated with reduced IM risk.
Exploring the Diagnostic Value of High-Frequency Ultrasound Technology for Subcutaneous Lipohypertrophy in Diabetes Patients Receiving Insulin Injections

Zhan-He Sun,Cheng-Hong Yu,Xin Wang

DOI: https://doi.org/10.2147/dmso.s443737

2024-03-20

Diabetes Metabolic Syndrome and Obesity Targets and Therapy

Abstract:Zhan-He Sun, &ast Cheng-Hong Yu, &ast Xin Wang Department of Ultrasound, Tongxiang First People's Hospital, Tongxiang, Zhejiang Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xin Wang, Email Objective: This study aims to investigate the clinical application value of high-frequency ultrasound technology in diagnosing subcutaneous lipohypertrophy at insulin injection sites in diabetes patients. Methods: All diabetes patients treated in our hospital from January 2022 to January 2023 were selected as the study subjects. The incidence of subcutaneous lipohypertrophy was calculated at the end of the study period. All patients were screened, and those meeting the inclusion criteria were registered, and basic data were collected. Patients were screened for subcutaneous lipohypertrophy using conventional clinical examination (control group) and high-frequency ultrasound technology (study group). Results: The study found that the incidence of subcutaneous lipohypertrophy in diabetes patients receiving insulin injections in our hospital from January 2022 to January 2023 was 80.99%. The average longitudinal diameter of subcutaneous lipohypertrophy in these patients was 11.66 (7.56, 21.44) mm, the transverse diameter was 12.04 (8.96, 18.29) mm, depth was (5.62± 2.17) mm, and the area was 188.79 (76.85, 331.78) mm2. The clinical detection rate in the study group was higher than that in the control group (P< 0.05). The quantity of detected sites was greater in the study group compared to the control group (P< 0.05). Conclusion: The incidence of subcutaneous lipohypertrophy in diabetes patients receiving insulin injections is relatively high clinically, and high-frequency ultrasound technology demonstrates significant potential in diagnosis. By providing high-resolution imaging and quantitative data, it effectively improves the clinical detection rate and clarifies symptoms. This technology is likely to become an important auxiliary tool in future diabetes treatment, providing more precise treatment plans for patients. Keywords: high-frequency ultrasound technology, diabetes, insulin injection, subcutaneous lipohypertrophy, diagnostic value Diabetes is a chronic metabolic disorder characterized by abnormal elevation of blood glucose levels due to insufficient insulin secretion or impaired insulin effectiveness. 1 Insulin, a hormone secreted by the pancreas, plays a crucial role in aiding cells in the body to absorb glucose, thereby maintaining normal blood glucose levels. 2 Insulin injection is a primary method of diabetes treatment, but subcutaneous lipohypertrophy has become a common yet challenging phenomenon during insulin injection therapy. 3 This hypertrophy not only affects the absorption and efficacy of insulin but may also lead to issues such as pain and bruising at the injection site, impacting the effectiveness of treatment. 4 High-frequency ultrasound technology not only provides visual imaging but also enables quantitative analysis. It utilizes the propagation characteristics of high-frequency sound waves in tissues to offer clear and real-time imaging of subcutaneous tissues. 5 Its advantages, including radiation-free and non-invasive features, allow for more frequent monitoring, providing timely feedback for treatment. Through high-resolution imaging of injection sites, healthcare professionals can visually observe the hypertrophy of the fat layer, offering a basis for treatment adjustments. 6 Given its potential value in detecting subcutaneous lipohypertrophy in diabetes patients, this article explores the possible significance and future applications of high-frequency ultrasound technology in diagnosing subcutaneous lipohypertrophy in diabetes patients receiving insulin injections. Real-time, high-definition imaging of injection sites holds the promise of a more comprehensive and accurate understanding of dynamic changes in subcutaneous tissues, providing robust support for the development of personalized treatment plans. In the face of the complex challenges in diabetes management, high-frequency ultrasound technology may emerge as a groundbreaking diagnostic tool, contributing positively to enhancing treatment outcomes and improving the quality of life for patients. This study aims to investigate the clinical application value of high-frequency ultrasound technology in diagnosing subcutaneous lipohypertrophy at insulin injection sites in diabetes patients. The primary endpoint of this study is to assess the incidence of subcutaneous lipohypertrophy in diabetes patients receiving insulin injections. The secondary endpoints include evaluating the size and cha -Abstract Truncated-

endocrinology & metabolism
Correction to “gut Microbiota Dysbiosis in Chinese Children with Type 1 Diabetes Mellitus: an Observational Study”

Xia Liu,Yi-Wen Cheng,Li Shao,Shu-Hong Sun,Jian Wu,Qing-Hai Song,Hong-Sheng Zou,Zong-Xin Ling

DOI: https://doi.org/10.3748/wjg.v28.i25.3006

IF: 5.374

2022-01-01

World Journal of Gastroenterology

Abstract:[This corrects the article on p. 2394 in vol. 27, PMID: 34040330.].
Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy

Jian Yu,Hong Wang,Min Zhu,Dan Yan,Boqiang Fan,Yun Shi,Min Shen,Xiaoyun Liu,Wei He,Dan Luo,Jingjing Xu

DOI: https://doi.org/10.1097/cm9.0000000000001742

IF: 6.133

2021-09-21

Chinese Medical Journal

Abstract:To the Editor: Lipohypertrophy (LH) is the most common local complication caused by multiple overlapping insulin injections. Clinically, LH manifests as prominent and/or thickened tissue at injection or infusion sites, sometimes resulting in lump formation under the skin. Histologically, LH is characterized by decreased vascularity, fibrosis, and adipocyte enlargement and proliferation in the subcutaneous tissue at insulin injection sites. Because of this, the existing screening methods for LH are mainly based on clinical examination and ultrasound scanning (USS). A recent systematic review revealed that only limited information is available for detection sensitivity among the different methods used to identify LH to date. Thus far, the gold standard examination for LH diagnosis remains debatable and there has been insufficient research on which patients require both kinds of examination. Currently, the detection sensitivity of USS vs. clinical examination for LH has not been reported in large sample-based studies. The present study aimed to compare the detection accuracy between USS and clinical examination using a large patient cohort and to determine the influencing factors for inconsistent detection results of LH between the two methods.

medicine, general & internal
Subcutaneous Insulin Resistance: a New Type of Insulin Resistance

Ming Zhao

2008-01-01

Abstract:Subcutaneous insulin resistance is a condition in which glucose is insensitive to insulin from the subcutaneous tissue,but sensitive to that by intravenous injection.The mechanism of subcutaneous insulin resistance is mainly associated with skin obstruction or delayed entry of insulin into blood circulation.The treatment of the problem involves Aprotinin,anticoagulant and intramuscular injection of insulin.This paper offers an overview of the advances in the researches of subcutaneous insulin resistance.
The relationship between insulin resistance/β-cell dysfunction and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study.

Xi-pu Liu,Xiu-fen Yang,H. Gu,Yun-Yun Li,T. Snellingen,N. Liu

DOI: https://doi.org/10.18240/ijo.2018.03.21

IF: 1.645

2018-03-18

International Journal of Ophthalmology

Abstract:AIM To investigate the relationship between insulin resistance (IR)/β-cell dysfunction and diabetic retinopathy (DR) in Chinese patients with type 2 diabetes mellitus (T2DM), and to explore further whether there were differences in the relationship among diabetic patients with higher and lower body mass index (BMI). METHODS Cross-sectional study. A total of 1466 subjects with T2DM were recruited in a local Desheng Community of urban Beijing from November 2009 to June 2012 for the cohort of Beijing Desheng Diabetic Eye Study. Standardized evaluation was carried out for each participant, including questionnaire, ocular and anthropometric examinations, and laboratory tests. Seven fields 30° color fundus photographs were used for DR grading according to the Early Treatment Diabetic Retinopathy Study protocols. Homeostatis Model Assessment (HOMA) method was employed for IR and β-cell function assessment. RESULTS After excluding those participants who were treated with insulin (n=352) or had missing data of fasting insulin (n=96), and further excluding those with poor quality of retinal photographs (n=10), a total of 1008 subjects were included for the final analysis, 406 (40.3%) were men and 602 (59.7%) were women, age ranging from 34 to 86 (64.87±8.28)y. Any DR (levels 14 and above) was present in 278 (27.6%) subjects. After adjusting for possible covariates, the presence of any DR did not correlate with HOMA IR [odds ratio (OR) 1.51, 95% confidence interval (CI) 0.87-2.61, P=0.14] or HOMA β-cell (OR 0.71, 95%CI 0.40-1.26, P=0.25). After stratification by BMI, the presence of any DR was associated positively with HOMA IR (OR 2.46, 95%CI: 1.18-5.12, P=0.016), and negatively with HOMA β-cell (OR 0.40, 95%CI: 0.19-0.87, P=0.021) in the group of patients with higher BMI (≥25 kg/m2). In the group of patients with lower BMI (<25 kg/m2), the presence of any DR was not associated with HOMA IR (OR 1.00, 95%CI: 0.43-2.33, P=1.00) or HOMA β-cell (OR 1.41, 95%CI: 0.60-3.32, P=0.43). CONCLUSION The data suggest that higher IR and lower β-cell function are associated with the presence of DR in the subgroup of diabetic patients with higher BMI. However, this association is not statistically significant in diabetic patients with lower BMI.

Medicine
The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals

Qi Pan,Lina Zhang,Aimin Gu,Dongni Yu,Xiaoxia Wang,Yan Zhou,Lixin Guo

DOI: https://doi.org/10.3389/fendo.2022.832726

IF: 6.055

2022-01-01

Frontiers in Endocrinology

Abstract:The absorption of needle-free fast-acting insulin injected into different body parts of healthy male subjects was studied in an attempt to provide clinical guidance for diabetic patients who take needle-free insulin injections in terms of providing reference in the clinical guidance regarding the correct use of needle-free insulin injections among diabetic patients. This randomized, open-label, cross-over trial was conducted on eight healthy adult male volunteers, in which the skin thickness at three injection sites (abdomen, upper arm, and thigh), the time to peak, peak rate, and area under the glucose infusion rate (GIR) curve of plasma insulin were measured through the hyperinsulin-normal glucose clamp test after the injection of insulin aspart with a needle-free syringe at three different sites to analyze the correlation between insulin absorption index at different injection sites and skin thickness. The values of the skin thickness of the abdomen, upper arm, and thigh measured by ultrasonic wave were 2.45 ± 0.34 mm, 2.18 ± 0.50 mm, and 1.93 ± 0.55 mm, respectively. There was a significant difference in the skin thickness of the abdomen and thigh (P = 0.014). The hyperinsulin-normal glucose clamp model was successfully established for each subject. Approximately 0–2 h after injection of insulin aspart with needle-free syringes, the area under the GIR-time curve of the abdomen, upper arm, and thigh was 29,400.75 ± 2,645.00 ml, 30,230.50 ± 4,937.87 ml, and 30,179.63 ± 6,188.57 ml, respectively. There was no significant difference in the area under the GIR curve between any two injection sites (P >0.05). The time to peak of GIR at different injection sites was 38.68 ± 13.57 min in the abdomen, 40.86 ± 12.70 min in the upper arm, and 37.03 ± 13.29 min in the thigh, respectively, in which no significant difference was found between each of them (P >0.05). The GIR curve after injection at the three different sites was consistent with each other. There was no significant difference in insulin absorption after the injection of insulin aspartate into the abdomen, upper arm, and thigh with a needleless syringe in healthy male adult volunteers, and there was no correlation between skin thickness at the injection site and insulin absorption. Injection sites did not affect the absorption of insulin in needle-free injections.
Development and validation of machine learning-augmented algorithm for insulin sensitivity assessment in the community and primary care settings: a population-based study in China

Hao Zhang,Tianshu Zeng,Jiaoyue Zhang,Juan Zheng,Jie Min,Miaomiao Peng,Geng Liu,Xueyu Zhong,Ying Wang,Kangli Qiu,Shenghua Tian,Xiaohuan Liu,Hantao Huang,Marina Surmach,Ping Wang,Xiang Hu,Lulu Chen

DOI: https://doi.org/10.3389/fendo.2024.1292346

IF: 6.055

2024-01-25

Frontiers in Endocrinology

Abstract:Objective: Insulin plays a central role in the regulation of energy and glucose homeostasis, and insulin resistance (IR) is widely considered as the "common soil" of a cluster of cardiometabolic disorders. Assessment of insulin sensitivity is very important in preventing and treating IR-related disease. This study aims to develop and validate machine learning (ML)-augmented algorithms for insulin sensitivity assessment in the community and primary care settings. Methods: We analyzed the data of 9358 participants over 40 years old who participated in the population-based cohort of the Hubei center of the REACTION study (Risk Evaluation of Cancers in Chinese Diabetic Individuals). Three non-ensemble algorithms and four ensemble algorithms were used to develop the models with 70 non-laboratory variables for the community and 87 (70 non-laboratory and 17 laboratory) variables for the primary care settings to screen the classifier of the state-of-the-art. The models with the best performance were further streamlined using top-ranked 5, 8, 10, 13, 15, and 20 features. Performances of these ML models were evaluated using the area under the receiver operating characteristic curve (AUROC), the area under the precision-recall curve (AUPR), and the Brier score. The Shapley additive explanation (SHAP) analysis was employed to evaluate the importance of features and interpret the models. Results: The LightGBM models developed for the community (AUROC 0.794, AUPR 0.575, Brier score 0.145) and primary care settings (AUROC 0.867, AUPR 0.705, Brier score 0.119) achieved higher performance than the models constructed by the other six algorithms. The streamlined LightGBM models for the community (AUROC 0.791, AUPR 0.563, Brier score 0.146) and primary care settings (AUROC 0.863, AUPR 0.692, Brier score 0.124) using the 20 top-ranked variables also showed excellent performance. SHAP analysis indicated that the top-ranked features included fasting plasma glucose (FPG), waist circumference (WC), body mass index (BMI), triglycerides (TG), gender, waist-to-height ratio (WHtR), the number of daughters born, resting pulse rate (RPR), etc. Conclusion: The ML models using the LightGBM algorithm are efficient to predict insulin sensitivity in the community and primary care settings accurately and might potentially become an efficient and practical tool for insulin sensitivity assessment in these settings.

endocrinology & metabolism
The Relationship Between β-cell Function Indices and Sudomotor Function in Chinese Patients with Type 2 Diabetes

Bai-Lu Cao,Yue Yao,Yi-Xin Xu,Jiang Fang,Wen-Jing Song,Bin Hu,Qing-Yu Guo,Bin Lu,Jie Li,Ping Gu,Jia-Qing Shao

DOI: https://doi.org/10.1055/a-0950-9828

Abstract:Purpose: SUDOSCAN, a new non-invasive, quick, sensitive and quantitative technique, has been developed to detect diabetic peripheral neuropathy, and the latter is believed to be correlated with impaired β-cell function. The purpose of the present study was to investigate the associations between β-cell function indices and sudomotor function in Chinese type 2 diabetes. Methods: A total of 266 Chinese patients with type 2 diabetes were enrolled. Sudomotor function was assessed using electrochemical skin conductance of hands and feet. Pancreatic β-cell function was determined by homeostasis model assessment of β-cell function index, early-phase β-cell function indices and total β-cell function indices. Pearson correlation analysis and multiple linear stepwise regression analysis were carried out to explore the associations between β-cell function indices and sudomotor function. Results: Patients with lower early-phase β-cell function had lower electrochemical skin conductance levels of hands and feet and higher asymmetry ratio of hands and feet. Both Pearson correlation analysis and multiple linear stepwise regression analysis showed significantly positive relationships between early-phase β-cell function and electrochemical skin conductance levels of hands and feet, after controlling for potential confounders (P<0.05). Conclusions: Impaired early-phase β-cell function was positively associated with sudomotor dysfunction in Chinese patients with type 2 diabetes. We speculated that impaired early-phase β-cell function may be associated with the incidence of sudomotor dysfunction in patients with T2DM.
Insulin Injection Technique in China Compared with the Rest of the World

Zhenqiang Song,Xiaohui Guo,Linong Ji,Xiao Huang,Laurence J Hirsch,Kenneth W Strauss

DOI: https://doi.org/10.1007/s13300-018-0525-y

Abstract:Introduction: Approximately 9 million people in China use insulin but little is known of their injection techniques (IT). Our aim was to understand IT in China via direct examination and a detailed survey. Methods: Injection Technique Questionnaire (ITQ) results of 3853 patients from 20 representative centers in China were compared with the Rest of World (ROW). Results: Insulin pens are used by 92% of Chinese insulin injectors, with > 3/4 using 4- or 5-mm pen needles. This is consistent with Chinese BMI values (and thus subcutaneous fat thickness) being lower than in ROW, raising the risk of IM (intramuscular) injections with longer needles. Total daily insulin dose is ~ 33 IU in China vs. 45 IU elsewhere. Lipohypertrophy (LH) rates are lower than in ROW, but still found in at least 25% of Chinese patients. Patients apparently do not realize they have LH or are unaware of the hazards of injecting into LH since many of them do so, and those who do use a mean of 11 IU more of insulin than non-LH patients. This incremental insulin use possibly costs the Chinese health care service around 2 billion RMB annually. Needle reuse is also frequent in China (78% vs. 48% ROW), and the high cost of pen needles is the main reason patients cite for reusing (25% use a single needle > 10×). Conclusion: This study reveals many areas in which Chinese professionals and patients can optimize injection practices and thereby improve outcomes and reduce costs. The official guidelines of the Chinese Diabetes Society, based on the FITTER recommendations, offer a roadmap for reaching this goal. Funding: BD Diabetes Care. Plain language summary available for this article.
Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients

Hui Guo,Chiyu Wang,Boren Jiang,Shaohong Ge,Jian Cai,Ying Zhou,Rong Ying,Kexi Zha,Ji Zhou,Ningjian Wang,Chunfang Zhu,Chenyu Cao,Liqin Zhang,Tao Gu,Yan Zhao,Yingli Lu,Zengmei An

DOI: https://doi.org/10.3389/fendo.2021.554604

IF: 6.055

2021-03-25

Frontiers in Endocrinology

Abstract:Background The interrelation between glucose and bone metabolism is complex and has not been fully revealed. This study aimed to investigate the association between insulin resistance, β-cell function and bone turnover biomarker levels among participants with abnormal glycometabolism. Methods A total of 5277 subjects were involved through a cross-sectional study (METAL study, http://www.chictr.org.cn , ChiCTR1800017573) in Shanghai, China. Homeostasis model assessment of insulin resistance (HOMA-IR) and β-cell dysfunction (HOMA-%β) were applied to elucidate the nexus between β-C-terminal telopeptide (β-CTX), intact N-terminal propeptide of type I collagen (P1NP) and osteocalcin (OC). β-CTX, OC and P1NP were detected by chemiluminescence. Results HOMA-IR was negatively associated with β-CTX, P1NP and OC (regression coefficient (β) -0.044 (-0.053, -0.035), Q4vsQ1; β -7.340 (-9.130, -5.550), Q4vsQ1 and β -2.885 (-3.357, -2.412), Q4vsQ1, respectively, all P for trend <0.001). HOMA-%β was positively associated with β-CTX, P1NP and OC (β 0.022 (0.014, 0.031), Q4vsQ1; β 6.951 (5.300, 8.602), Q4vsQ1 and β 1.361 (0.921, 1.800), Q4vsQ1, respectively, all P for trend <0.001). Conclusions Our results support that lower bone turnover biomarker (β-CTX, P1NP and OC) levels were associated with a combination of higher prevalence of insulin resistance and worse β-cell function among dysglycemia patients. It is feasible to detect bone turnover in diabetes or hyperglycemia patients to predict the risk of osteoporosis and fracture, relieve patients’ pain and reduce the expenses of long-term cure.

endocrinology & metabolism

Skin and Subcutaneous Tissue Thickness at Insulin Injection Sites in Chinese Diabetes Patients: Clinical Implications

Prevalence of Lipohypertrophy in Insulin-Treated Diabetes Patients: A Systematic Review and Meta-Analysis

Artificial Intelligence-Assisted Bioinformatics, Microneedle, and Diabetic Wound Healing: A "new Deal" of an Old Drug.

Establishment of Hyperinsulinemic Euglycemic Clamp Technique and the Reference Value of Insulin Sensitivity Index in Chinese

Can the Upper Inner Side of the Thigh Become a New Option for Insulin Injection?

Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients with and Without Diabetes.

Correction to: Insulin Injection Technique in China Compared with the Rest of the World

Subclinical lipohypertrophy——Easily ignored complications of insulin therapy

Insulin Injection Technique and Related Complications in Patients With Diabetes in a Northwest City of China

Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: A prospective cohort study in China

Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study

Exploring the Diagnostic Value of High-Frequency Ultrasound Technology for Subcutaneous Lipohypertrophy in Diabetes Patients Receiving Insulin Injections

Correction to “gut Microbiota Dysbiosis in Chinese Children with Type 1 Diabetes Mellitus: an Observational Study”

Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy

Subcutaneous Insulin Resistance: a New Type of Insulin Resistance

The relationship between insulin resistance/β-cell dysfunction and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study.

The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals

Development and validation of machine learning-augmented algorithm for insulin sensitivity assessment in the community and primary care settings: a population-based study in China

The Relationship Between β-cell Function Indices and Sudomotor Function in Chinese Patients with Type 2 Diabetes

Insulin Injection Technique in China Compared with the Rest of the World

Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients